Annexon ANNX 深 滬
等待開盤 09-20 09:30:00 美东时间
7.025
+0.095
+1.37%
華盛通- 最 高7.26
- 今 開7.10
- 成交量 148.47万股
- 最 低 6.93
- 昨 收 6.93
- 總市值 5.50亿
- 52周最高 8.40
- 市盈率 靜 --
- 換手率 1.90%
- 52周最低 1.57
- 委 比 -76.60%
- 總股本 7833.81万
- 歷史最高 38.01
- 量 比 0.92
- 振 幅 4.76%
- 歷史最低 1.57
- 每 手 1
- 風險率 1.51%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | 安纳克森公司：JP摩根将目标价从12美元下调至11美元。
Annexon Inc : JP Morgan Cuts Target Price to $11 From $12
08-14 12:37
Buy Rating Affirmed for Annexon Biosciences Amid Promising Clinical Trial Results
Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Annexon Biosc...
08-13 18:29
Needham Reiterates Buy on Annexon, Maintains $16 Price Target
Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.
08-13 17:54
Annexon Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-13 17:52
快讯 | annexon提交招股书，可能从时间到时间出售高达3百万股普通股的内部股东股票。
Annexon Files Prospectus for Possible Offer, Resale by Selling Stockholders Fro...
08-13 05:01
Annexon Biosciences GAAP EPS of -$0.23
Annexon Biosciences press release (NASDAQ:ANNX): Q2 GAAP EPS of -$0.23. Cash, cash equivalents and short-term investments were $368.7 million as of June 30, 2024. More on Annexon Biosciences Annexon: ...
08-12 20:34
Annexon Q2 EPS $(0.23), Inline
Annexon (NASDAQ:ANNX) reported quarterly losses of $(0.23) per share which met the analyst consensus estimate. This is a 51.06 percent increase over losses of $(0.47) per share from the same period last year.
08-12 20:09
快讯 | Annexon公司：C1Q抑制剂Anx007阶段3 Archer II试验开始患者计量
Annexon Inc: Patient Dosing Initiated in Phase 3 Archer II Trial of C1Q Inhibit...
08-05 20:14
快讯 | 预计在2026年下半年公布主要数据的Annexon公司。
Annexon Inc: Topline Data Expected in Second Half 2026
08-05 20:14
快讯 | Annexon就地理性萎缩患者的Archer II全球注册计划提供更新
Annexon Provides Update on Archer II Global Registrational Program in Geographi...
08-05 20:00
